Publications

Balyan, R; Hahn, D; Huang, H; Chidambaran, V. Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic. Expert Opinion on Drug Metabolism and Toxicology. 2020; 16:125-141.

Bauman, LE; Xiong, Y; Mizuno, T; Minar, P; Fukuda, T; Dong, M; Rosen, MJ; Vinks, AA. Improved Population Pharmacokinetic Model for Predicting Optimized Infliximab Exposure in Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 2020; 26:429-439.

Chen, Y; Sun, L; Xu, H; Dong, M; Mizuno, T; Vinks, AA; Brunner, HI; Li, Y; Li, Z. PK/PD Study of Mycophenolate Mofetil in Children With Systemic Lupus Erythematosus to Inform Model-Based Precision Dosing. Frontiers in Pharmacology. 2020; 11.

Emoto, C; Hahn, D; Euteneuer, JC; Mizuno, T; Vinks, AA; Fukuda, T. Next Challenge From the Variance in Individual Physiologically-Based Pharmacokinetic Model-Predicted to Observed Morphine Concentration in Critically Ill Neonates. Clinical Pharmacology and Therapeutics. 2020; 107:319-320.

Emoto, C; McPhail, BT; Fukuda, T. Clinical Applications of Physiologically Based Pharmacokinetic Modeling: Perspectives on the Advantages and Challenges. Therapeutic Drug Monitoring. 2020; 42:157-158.

Euteneuer, JC; Mizuno, T; Fukuda, T; Zhao, J; Setchell, KD R; Muglia, LJ; Vinks, AA. Model-Informed Bayesian Estimation Improves the Prediction of Morphine Exposure in Neonates and Infants. Therapeutic Drug Monitoring. 2020; 42:778-786.

Girdwood, ST; Arbough, T; Dong, M; Mizuno, T; Tang, P; Vinks, AA; Kaplan, J. Molecular Adsorbent Recirculating System Therapy with Continuous Renal Replacement Therapy Enhanced Clearance of Piperacillin in a Pediatric Patient and Led to Failure to Attain Pharmacodynamic Targets. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2020; 40:1061-1068.

Hahn, D; Fukuda, T; Euteneuer, JC; Mizuno, T; Vinks, AA; Sadhasivam, S; Emoto, C. Influence of MRP3 Genetics and Hepatic Expression Ontogeny for Morphine Disposition in Neonatal and Pediatric Patients. Journal of Clinical Pharmacology. 2020; 60:992-998.

Jodele, S; Dandoy, CE; Lane, A; Laskin, BL; Laskin, B; Teusink-Cross, A; Myers, KC; Wallace, G; Nelson, AS; Nelson, A; et al. Complement blockade for TA-TMA: Lessons learned from a large pediatric cohort treated with eculizumab. Blood. 2020; 26:S138-S138.

McPhail, BT; Emoto, C; Fukuda, T; Butler, D; Wiles, JR; Akinbi, H; Vinks, AA. Utilizing Pediatric Physiologically Based Pharmacokinetic Models to Examine Factors That Contribute to Methadone Pharmacokinetic Variability in Neonatal Abstinence Syndrome Patients. Journal of Clinical Pharmacology. 2020; 60:453-465.

Meier, ER; Creary, SE; Heeney, MM; Dong, M; Appiah-Kubi, AO; Nelson, SC; Niss, O; Piccone, C; Quarmyne, MO; Quinn, CT; et al. Hydroxyurea Optimization through Precision Study (HOPS): study protocol for a randomized, multicenter trial in children with sickle cell anemia. Trials. 2020; 21.

Somberg, JC; Vinks, AA; Dong, M; Molnar, J. Model-Informed Development of Sotalol Loading and Dose Escalation Employing an Intravenous Infusion. Cardiology Research. 2020; 11:294-304.

Tang Girdwood, SC; Mizuno, T; Krallman, KA; Benken, LA; Stoneman, EM; Yunger, TM; Wong, HR; Vinks, AA; Kaplan, JM. Route of oseltamivir administration affects metabolite concentrations in critically ill children. The Pediatric Infectious Disease Journal. 2020; 38:1224-1227.

Taylor, ZL; Mizuno, T; Punt, NC; Baskaran, B; Sainz, AN; Shuman, W; Felicelli, N; Vinks, AA; Heldrup, J; Ramsey, LB. MTXPK.org: A Clinical Decision Support Tool Evaluating High-Dose Methotrexate Pharmacokinetics to Inform Post-Infusion Care and Use of Glucarpidase. Clinical Pharmacology and Therapeutics. 2020; 108:635-643.

Ullrich, NJ; Prabhu, SP; Reddy, AT; Fisher, MJ; Packer, R; Goldman, S; Robison, NJ; Gutmann, DH; Viskochil, DH; Allen, JC; et al. A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: A Neurofibromatosis Clinical Trials Consortium study. Neuro-Oncology. 2020; 22:1527-1535.

van Hoogdalem, MW; Emoto, C; Fukuda, T; Mizuno, T; Mehta, PA; Vinks, AA. Population pharmacokinetic modelling of busulfan and the influence of body composition in paediatric Fanconi anaemia patients. British Journal of Clinical Pharmacology. 2020; 86:933-943.

Vinks, AA; Peck, RW; Neely, M; Mould, DR. Development and Implementation of Electronic Health Record–Integrated Model-Informed Clinical Decision Support Tools for the Precision Dosing of Drugs. Clinical Pharmacology and Therapeutics. 2020; 107:129-135.

Vinks, AA; Punt, NC; Menke, F; Kirkendall, E; Butler, D; Duggan, TJ; Cortezzo, DE; Kiger, S; Dietrich, T; Spencer, P; et al. Electronic Health Record–Embedded Decision Support Platform for Morphine Precision Dosing in Neonates. Clinical Pharmacology and Therapeutics. 2020; 107:186-194.

Ware, RE; Marahatta, A; Ware, JL; McElhinney, K; Dong, M; Vinks, AA. Hydroxyurea Exposure in Lactation: a Pharmacokinetics Study (HELPS). The Journal of Pediatrics. 2020; 222:236-239.